kathimerini.gr
Malaria Research Targets Deadly Parasite Amidst Climate Change Threat
Malaria, caused by Plasmodium parasites transmitted by Anopheles mosquitos, infects 250 million and kills nearly 500,000 annually; Dr. Katerina Artavanides-Chakona's research at Cambridge University uses ubiquitin to target the deadliest parasite, Plasmodium falciparum, aiming for new treatments.
- What are the most significant challenges in combating malaria, and how is climate change exacerbating the problem?
- Malaria, a disease affecting 250 million people annually, primarily in sub-Saharan Africa, results in nearly 500,000 deaths, mostly children under five. Research by Dr. Katerina Artava- nides-Chakona at Cambridge University focuses on the deadliest malaria parasite, Plasmodium falciparum, aiming to develop new treatments.
- How does the research on ubiquitin contribute to developing new malaria treatments, and what are the potential benefits of this approach?
- The Plasmodium falciparum parasite's ability to evade the immune system by altering its surface proteins every 48 hours complicates the development of effective treatments and vaccines. Dr. Artava- nides-Chakona's research uses ubiquitin, a key protein in cellular function, to target the parasite's survival and multiplication.
- Considering the parasite's evolutionary adaptation and the challenges in vaccine and drug development, what are the most promising avenues for long-term malaria control?
- Climate change is expanding malaria's reach, potentially exposing over 5 billion people by 2040 due to rising temperatures and population growth. This resurgence threatens to reintroduce malaria to countries that had eradicated it, necessitating urgent research for new treatments and preventative measures.
Cognitive Concepts
Framing Bias
The article frames the narrative around Dr. Artavanis-Tsakona's research, showcasing her work and perspective prominently. While this highlights important advancements, it might overshadow other crucial aspects of malaria prevention and control efforts.
Language Bias
The language used is largely neutral and objective. However, phrases such as "most dangerous and deadly," "grim reaper," and "grim challenge" could be considered somewhat sensationalistic or emotionally charged. More neutral alternatives could be used to maintain scientific objectivity.
Bias by Omission
The article focuses heavily on the research of Dr. Artavanis-Tsakona and the biology of malaria, but it omits discussion of other significant research efforts or approaches to combating the disease. While it mentions the existence of other antimalarial drugs and vaccines, it doesn't explore their limitations or successes in detail. This omission might give readers a skewed perception of the current state of malaria research.
Gender Bias
The article focuses on Dr. Artavanis-Tsakona's personal journey and achievements. While this is appropriate given the focus on her research, it doesn't necessarily represent a gender bias. The article doesn't focus on her appearance or personal details irrelevant to her scientific work. More broadly, however, a focus solely on one female scientist might implicitly suggest a lack of other significant female contributors to malaria research. The article could benefit from mentioning other notable female researchers in the field.
Sustainable Development Goals
The article discusses research on malaria, a major global health issue. The research focuses on developing new treatments and vaccines, directly contributing to improved health outcomes and reducing the disease burden. The connection is direct because the research aims to improve global health by addressing a significant infectious disease.